Modeling hospital discharge policies for patients with pneumonia-related sepsis

IIE Transactions (Institute of Industrial Engineers)

Volumn 40, Issue 9, 2008, Pages 853-860

  Kreke, Jennifer E ^a   Bailey, Matthew ^b   Schaefer, Andrew J ^a   Angus, Derek ^c   Roberts, Mark S ^c  

^a University of Pittsburgh   (United States)

^b BUCKNELL UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Markov decision processes; Medical decision making; Patient management; Pneumonia; Sepsis

Indexed keywords

DISCHARGE (FLUID MECHANICS); FLUID MECHANICS; HEALTH CARE; HOSPITALS;

BILLION (CO); CLINICAL STUDIES; DISEASE PROGRESSIONS; GENERAL MODEL; HEALTH CARE COSTS; HOSPITAL DISCHARGE; LENGTH OF STAY (LOS); PARAMETERIZED; PATIENT HEALTH; PROBLEM INSTANCES; SIGNIFICANT FACTOR; UNITED STATES;

HEALTH;

EID: 48249083514     PISSN: 0740817X     EISSN: 15458830     Source Type: Journal    
DOI: 10.1080/07408170802165872     Document Type: Article

References (40)

1. Alagoz, O., Maillart, L. M., Schaefer, A. J. and Roberts, M. S. (2004) The optimal timing of living-donor liver transplantation. 50:10, pp. 1420-1430.
2. Alagoz, O., Maillart, L. M., Schaefer, A. J. and Roberts, M. S. (2007) Determining the acceptance of cadaveric livers using an implicit model of the waiting list. 55:1, pp. 24-36.
3. Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J. and Pinsky, M. P. (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. 29:7, pp. 1303-1310.
4. Anon (2006)
5. Barlow, R. E. and Proschan, F. (1965) Wiley, New York, NY
6. Bertsekas, D. P. (2001) Athena Scientific, Bemont, MA
7. Bitran, G. R. and Tirupati, D. (1993) Hierarchical production planning. pp. 523-568. North-Holland, Amsterdam, The Netherlands
8. Bone, R. C. (1996) Why sepsis trials fail. 276, pp. 565-566.
9. Burchardi, H. and Schneider, H. (2004) Economic aspects of severe sepsis: A review of intensive care unit costs, cost of illness and cost effectiveness of therapy. 22:12, pp. 793-813.
10. Burns, L. and Wholey, D. (1991) The effects of patient, hospital, and physician characteristics on length of stay and mortality. 29, pp. 225-271.
11. Cleary, P. D., Greenfield, S., Mulley, A. G., Pauker, S. G., Schroeder, S. A., Wexler, L. and McNeil, B. J. (1991) Variation in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. 266, pp. 73-89.
12. Clermont, G., Angus, D. C., Kalassian, K. G., Linde-Zwirble, W. T., Ramakrishnan, N., Linden, P. K. and Pinsky, M. R. (2003) Reassessing the value of short-term mortality in sepsis: Comparing conventional approaches to modeling. 31:11, pp. 2627-2633.
13. Clermont, G., Angus, D. C., Linde-Zwirble, W. T., Griffin, M. F., Fine, M. J. and Pinsky, M. R. (2002) Does acute organ dysfunction predict patient-centered outcomes?. 121:6, pp. 1963-1971.
14. Clermont, G., Kaplan, V., Moreno, R., Vincent, J. L., Linde-Zwirble, W. T., Van Hout, B. and Angus, D. C. (2004) Dynamic microsimulation to model multiple outcomes in cohorts of critically ill patients. 30, pp. 2237-2255.
15. Davies, A., Ridley, S., Hutton, J., Chinn, C., Barber, B. and Angus, D. C. (2005) Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom. 60:2, pp. 155-162.
16. D'Epenoux, F. (1963) A probabalistic production and inventory problem. 10:1, pp. 98-108.
17. Eggimann, P. and Pittet, D. (2001) Infection control in the ICU. 120:6, pp. 2059-2093.
18. Ferriera, F. L., Bota, D. P., Bross, A., Melot, C. and Vincent, J. -L. (2001) Serial evaluation of the SOFA score to predict outcome in critically ill patients. 286:14, pp. 1754-1758.
19. Fine, M. J., Hough, L. J., Medsger, A. R., Li, Y. H., Ricci, E. M., Singer, D. E., Marrie, T. J., Coley, C. M., Walsh, M. B., Karpf, M., Lahive, K. C. and Kapoor, W. N. (1997) The hospital discharge decision in patients with community-acquired pneumonia: Results from the pneumonia PORT cohort study. 157, pp. 47-56.
20. Fine, M. J., Singer, D. E., Phelps, A. L., Hanusa, B. H. and Kapoor, W. N. (1993) Differences in length of hospital stay in patients with community-acquired pneumonia: A prospective four hospital study. 31, pp. 371-380.
21. Halm, E. A., Fine, M. J., Marrie, T. J., Coley, C. M., Kapoor, W. N., Obrosky, D. S. and Singer, D. E. (1998) Time to clinical stability in patients hospitalized with community-acquired pneumonia. 279:18, pp. 1452-1457.
22. Hotchkiss, R. S. and Karl, I. E. (2003) The pathology and treatment of sepsis. 348:2, pp. 138-150.
23. Hoyert, D. L., Heron, M. P., Murphy, S. L. and Kung, H. -C. (2006) Deaths: Final data for 2003. 54:13, p. 5.
24. Iglehart, D. L. (1963) Optimality of (s,S) policies in the infinite horizon dynamic inventory problem. 9:2, pp. 259-267.
25. Johnston, J. A. (2005) Determinants of mortality in patients with severe sepsis. 25, pp. 374-386.
26. Kasal, J., Jovanovic, Z., Clermont, G., Weissfeld, L. A., Kaplan, V., Watson, R. S. and Angus, D. C. (2004) Comparison of Cox and Gray's survival models in severe sepsis. 32:3, pp. 700-707.
27. Kreke, J. E. (2007) PhD thesis. University of Pittsburgh, Pittsburgh, PA
28. Marshall, J. C. (2000) Clinical trials of mediator-directed therapy in sepsis: What have we learned?. 26, pp. S75-S83.
29. McCormick, D., Fine, M. J., Coley, C. M., Marrie, T. J., Lave, J. R., Obrosky, D. S., Kapoor, W. N. and Singer, D. E. (1999) Variation in length of hospital stay in patients with community acquired pneumonia: Are shorter stays associated with worse medical outcomes?. 107:1, pp. 5-12.
30. Puterman, M. L. (1994) Wiley, New York, NY
31. Quartin, A. A., Schein, R. M., Kett, D. H. and Peduzzi, P. N. (1997) Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. 277, pp. 1058-1063.
32. Rangel-Frausto, M. S., Pittet, D., Costigan, M., Hwang, T., Davis, C. S. and Wenzel, R. P. (1995) The natural history of the systemic inflammatory response syndrome (SIRS): A prospective study. 273:2, pp. 117-123.
33. Riedemann, N. C., Guo, R. F. and Ward, P. A. (2003) Novel strategies for the treatment of sepsis. 9, pp. 517-524.
34. Roman-Marchant, O., Orellana-Jimenez, C. E. A., De Backer, D., Merlot, C. and Vincent, J. -L. (2004) Septic shock of early or late onset: Does it matter?. 126:1, pp. 173-178.
35. Schaefer, A. J., Bailey, M. D., Shechter, S. M. and Roberts, M. S. (2004) Modeling medical treatment using Markov decision processes. pp. 597-616. Kluwer, Boston
36. Shechter, S. M., Bailey, M. D., Schaefer, A. J. and Roberts, M. S. (2007) The optimal time to initiate HIV therapy under ordered health states. 56:1, pp. 20-33.
37. Vincent, J. -L., Moreno, R., Takala, J., Willatts, S., De Medonca, A., Bruining, H., Reinhart, C. K., Suter, R. M. and Thijs, L. G. (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. 22, pp. 707-710.
38. Weycker, D., Akhras, K. S., Edelsberg, J., Angus, D. C. and Oster, G. (2003) Long-term mortality and medical care changes in patients with severe sepsis. 31:9, pp. 2316-2123.
39. Wheeler, A. P. and Bernard, G. R. (1999) Current concepts: Treating patients with severe sepsis. 340:3, pp. 207-214.
40. Zeni, F., Freeman, B. F. and Natanson, C. (1997) Anti-inflammatory therapies to treat sepsis and septic shock: A reassessment. 25, pp. 1095-1100.